• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4606055)   Today's Articles (1030)   Subscriber (49373)
For: Yoshida Y, Fujiwara M, Kinoshita M, Sada K, Miyamoto S, Ozeki Y, Iwamoto M, Mori Y, Nagai S, Matsuda N, Noguchi T, Okamoto M, Gotoh K, Masaki T, Shibata H. Effects of esaxerenone on blood pressure, urinary albumin excretion, serum levels of NT-proBNP, and quality of life in patients with primary aldosteronism. Hypertens Res 2024;47:157-167. [PMID: 37717115 DOI: 10.1038/s41440-023-01412-w] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2023] [Revised: 07/26/2023] [Accepted: 08/05/2023] [Indexed: 09/18/2023]
Number Cited by Other Article(s)
1
Yoshida Y, Shibata H. Relations between glomerular hyperfiltration and podocyte injury: potential role of Piezo1 in the Rac1-mineralocorticoid receptor activation pathway. Hypertens Res 2024;47:1092-1094. [PMID: 38337007 DOI: 10.1038/s41440-024-01603-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/03/2024] [Accepted: 01/17/2024] [Indexed: 02/12/2024]
2
Yoshida Y, Shibata H. No "U-shaped" associations of estimated glomerular filtration rate with adverse cardiovascular outcomes in patients with primary aldosteronism. Hypertens Res 2024;47:247-249. [PMID: 37945892 DOI: 10.1038/s41440-023-01506-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2023] [Revised: 10/08/2023] [Accepted: 10/11/2023] [Indexed: 11/12/2023]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA